Solamargine
Based on 12 publication(s) in Google Scholar
Solamargine, a derivative from the steroidal solasodine in Solanum species, exhibits anticancer activities in numerous types of cancer. Solamargine induces non-selective cytotoxicity and P-glycoprotein inhibition. Solamargine significantly inhibits migration and invasion of HepG2 cells by down-regulating MMP-2 and MMP-9 expression and activity.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.87%
- No. CAS: 20311-51-7
- Fòrmula: C45H73NO15
- Peso molecular:868.06
-
Almacenamiento:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Solamargine
More- Food Chem. 2020 May 15:312:126030. [Abstract]
- Int J Oncol. 2019 May;54(5):1545-1554. [Abstract]
- Int J Oncol. 2019 Mar;54(3):905-915. [Abstract]
- Cancers (Basel). 2019 Mar 12;11(3):353. [Abstract]
- J Food Sci. 2019 Feb;84(2):235-243. [Abstract]
- J Sci Food Agric. 2019 May;99(7):3578-3587. [Abstract]
- J Food Drug Anal. 2018 Apr;26(2):751-760. [Abstract]
- Oncol Lett. 2023 Sep 28;26(5):493. [Abstract]
- Eur J Histochem. 2025 Jun 17;69(3). [Abstract]
- Rapid Commun Mass Spectrom. 2020 Oct 15;34(19):e8882. [Abstract]
- bioRxiv. 2024 Mar 20.
- J Oncol. 2022 Mar 10:2022:9055954. [Abstract]
-
WB
Actividad biológica
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
8 μM
Compound: 1, Solamargine
|
Cytotoxicity against human A549 cells by MTT assay
Cytotoxicity against human A549 cells by MTT assay
|
[PMID: 21482107] |
| A549 | IC50 |
8.18 μM
Compound: SM
|
Cytotoxicity against human A549 cells assessed as cell viability after 24 hrs by MTT assay
Cytotoxicity against human A549 cells assessed as cell viability after 24 hrs by MTT assay
|
[PMID: 24534485] |
| H9c2 | IC50 |
>20 μM
Compound: 1, Solamargine
|
Cytotoxicity against rat H9c2 cells by MTT assay
Cytotoxicity against rat H9c2 cells by MTT assay
|
[PMID: 21482107] |
| HCT-116 | IC50 |
3.8 μM
Compound: 1, Solamargine
|
Cytotoxicity against human HCT116 cells by MTT assay
Cytotoxicity against human HCT116 cells by MTT assay
|
[PMID: 21482107] |
| HeLa | IC50 |
6 μM
Compound: 1, Solamargine
|
Cytotoxicity against human HeLa cells by MTT assay
Cytotoxicity against human HeLa cells by MTT assay
|
[PMID: 21482107] |
| HepG2 | IC50 |
2.5 μM
Compound: 1, Solamargine
|
Cytotoxicity against human HepG2 cells by MTT assay
Cytotoxicity against human HepG2 cells by MTT assay
|
[PMID: 21482107] |
| HepG2 | IC50 |
2.67 μM
Compound: SM
|
Cytotoxicity against human HepG2 cells assessed as cell viability after 24 hrs by MTT assay
Cytotoxicity against human HepG2 cells assessed as cell viability after 24 hrs by MTT assay
|
[PMID: 24534485] |
| K562 | IC50 |
5.2 μM
Compound: 1, Solamargine
|
Cytotoxicity against human K562 cells by MTT assay
Cytotoxicity against human K562 cells by MTT assay
|
[PMID: 21482107] |
| L02 | IC50 |
13.23 μM
Compound: SM
|
Cytotoxicity against human HL-7702 cells assessed as cell viability after 24 hrs by MTT assay
Cytotoxicity against human HL-7702 cells assessed as cell viability after 24 hrs by MTT assay
|
[PMID: 24534485] |
| L02 | IC50 |
13.5 μM
Compound: 1, Solamargine
|
Cytotoxicity against human HL-7702 by MTT assay
Cytotoxicity against human HL-7702 by MTT assay
|
[PMID: 21482107] |
| MCF7 | IC50 |
2.1 μM
Compound: 1, Solamargine
|
Cytotoxicity against human MCF7 cells by MTT assay
Cytotoxicity against human MCF7 cells by MTT assay
|
[PMID: 21482107] |
| MCF7 | IC50 |
8.12 μM
Compound: SM
|
Cytotoxicity against human MCF7 cells assessed as cell viability after 24 hrs by MTT assay
Cytotoxicity against human MCF7 cells assessed as cell viability after 24 hrs by MTT assay
|
[PMID: 24534485] |
| PLC-PRF-5 | ED50 |
1.53 μg/mL
Compound: solamargine
|
Cytotoxicity against human PLC/PRF/5 cells by microassay
Cytotoxicity against human PLC/PRF/5 cells by microassay
|
[PMID: 2380724] |
| U-87MG ATCC | IC50 |
3.2 μM
Compound: 1, Solamargine
|
Cytotoxicity against human U87 cells by MTT assay
Cytotoxicity against human U87 cells by MTT assay
|
[PMID: 21482107] |
Solamargine (15 μg/ml; 72 hours) predominantly stimulates the cells of the G2/M phase to apoptosis[3].
Solamargine (72 hours) dramatically inhibits the proliferation of SMMC-7721 and HepG2 cells in a dose- and time-dependent manner. The IC50s are 9.21 and 19.88 μg/ml, respectively[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SMMC-7721cells
-
Concentration:15 μg/ml
-
Incubation Time:72 hours
-
Result:Displayed a significant increase of sub-G1.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female specific pathogen-free BALB/c nude mice weighing 18-20 g (6-8-weeks-old)[4]
-
Dosage:10 mg/kg
-
Administration:Intragastric administration; once daily for 8 days
-
Result:Tumor growth was significantly inhibited .
Chemical Information
-
No. CAS 20311-51-7
-
Appearance Solid
-
Peso molecular 868.06
-
Fòrmula C45H73NO15
-
Color White to off-white
-
SMILES
C[C@H](CC1)CN[C@]21O[C@@]3([H])C[C@@]4([H])[C@]5([H])CC=C6C[C@@H](O[C@@]7([H])[C@H](O[C@@]8([H])[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O8)[C@@H](O)[C@H](O[C@]9([H])O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O)[C@@H](CO)O7)CC[C@]6(C)[C@@]5([H])CC[C@]4(C)[C@@]3([H])[C@@H]2C
-
Synonyms
Solamargin; δ-Solanigrine
-
Structure Classification
-
Initial Source
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (12)
-
Journal Impact Factor
-
Most Recent
-
Food Chem
Simultaneous quantification of polyphenols, glycoalkaloids and saponins in African nightshade leaves using ultra-high performance liquid chromatography tandem mass spectrometry with acid assisted hydrolysis and multivariate analysis. [Abstract]2020 May 15:312:126030. PMID: 31911353 -
Int J Oncol
Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway. [Abstract]2019 May;54(5):1545-1554. PMID: 30864686 -
Int J Oncol
2019 Mar;54(3):905-915. PMID: 30483763
Solamargine purchased from MedChemExpress. Usage Cited in: Int J Oncol. 2019 Mar;54(3):905-915. [Abstract]
Western blot analysis for the protein expression of XIAP, survivin, Ki‑67, PCNA and cyclin D1 in the treatment of MOCK, solamargine and Fe3O4-solamargine.
-
Cancers (Basel)
Long-Term Exposure to Oroxylin A Inhibits Metastasis by Suppressing CCL2 in Oral Squamous Cell Carcinoma Cells. [Abstract]2019 Mar 12;11(3):353. PMID: 30871117 -
J Food Sci
Identification of Polyphenols, Glycoalkaloids, and Saponins in Solanum scabrum Berries Using HPLC-UV/Vis-MS. [Abstract]2019 Feb;84(2):235-243. PMID: 30693503 -
J Sci Food Agric
Quantity assessment of polyphenols, glycoalkaloids and saponins in Solanum scabrum berries of different genetic sources and maturity by HPLC/UV-visible/MS methods. [Abstract]2019 May;99(7):3578-3587. PMID: 30628085 -
J Food Drug Anal
Rapid screening of toxic glycoalkaloids and micronutrients in edible nightshades (Solanum spp.). [Abstract]2018 Apr;26(2):751-760. PMID: 29567246 -
Oncol Lett
Solamargine induces apoptosis of human renal carcinoma cells via downregulating phosphorylated STAT3 expression. [Abstract]2023 Sep 28;26(5):493. PMID: 37854861 -
Eur J Histochem
Solamargine inhibited the progression of non-small cell lung cancer in vitro by activating T cells. [Abstract]2025 Jun 17;69(3). PMID: 40888491 -
Rapid Commun Mass Spectrom
Rapid screening of glycoalkaloids in Solanum scabrum and S. nigrum berries using ultra-high-performance liquid chromatography with pathway-specified in-source fragmentation tandem mass spectrometry. [Abstract]2020 Oct 15;34(19):e8882. PMID: 32644256 -
-
J Oncol
Solamargine Inhibits Prostate Cancer Cell Growth and Enhances the Therapeutic Efficacy of Docetaxel via Akt Signaling. [Abstract]2022 Mar 10:2022:9055954. PMID: 35310915
Solvente y solubilidad
DMSO : 100 mg/mL (115.20 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (2.88 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (2.88 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureza y Documentación
-
Ficha de datos (277 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Burger T, et al. Solamargine, a bioactive steroidal alkaloid isolated from Solanum aculeastrum induces non-selective cytotoxicity and P-glycoprotein inhibition. BMC Complement Altern Med. 2018 May 2;18(1):137. [Content Brief]
[2]. Sani IK, et al. Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity. Toxicol In Vitro. 2015 Aug;29(5):893-900. [Content Brief]
[3]. Ding X, et al. Induction of apoptosis in human hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. J Ethnopharmacol. 2012 Jan 31;139(2):599-604. [Content Brief]
[4]. Fu R, et al. Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway. Int J Oncol. 2019 May;54(5):1545-1554. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.1520 mL | 5.7600 mL | 11.5199 mL | 28.7999 mL |
| 5 mM | 0.2304 mL | 1.1520 mL | 2.3040 mL | 5.7600 mL | |
| 10 mM | 0.1152 mL | 0.5760 mL | 1.1520 mL | 2.8800 mL | |
| 15 mM | 0.0768 mL | 0.3840 mL | 0.7680 mL | 1.9200 mL | |
| 20 mM | 0.0576 mL | 0.2880 mL | 0.5760 mL | 1.4400 mL | |
| 25 mM | 0.0461 mL | 0.2304 mL | 0.4608 mL | 1.1520 mL | |
| 30 mM | 0.0384 mL | 0.1920 mL | 0.3840 mL | 0.9600 mL | |
| 40 mM | 0.0288 mL | 0.1440 mL | 0.2880 mL | 0.7200 mL | |
| 50 mM | 0.0230 mL | 0.1152 mL | 0.2304 mL | 0.5760 mL | |
| 60 mM | 0.0192 mL | 0.0960 mL | 0.1920 mL | 0.4800 mL | |
| 80 mM | 0.0144 mL | 0.0720 mL | 0.1440 mL | 0.3600 mL | |
| 100 mM | 0.0115 mL | 0.0576 mL | 0.1152 mL | 0.2880 mL |